Comparison of PICC and Implantable Intravenous Port in Chemotherapy Patients
化疗患者应用PICC与植入式静脉输液港的比较

摘要

目的 了解PICC与植入式静脉输液港在化疗患者治疗中的具体应用，并对其使用效果进行观察和比较。方法 本次研究由我院接受化疗的恶性肿瘤患者参与实施，共计人数58例，于2021年1月－12月期间收治。根据要求，所有患者以1:1的比例分两组进行，每组患者使用不同的静脉输液途径，具体包含PICC、植入式静脉输液港两种，分别对应于29例患者，前后以对照组、观察组的形式展开比较研究。结果 从两组患者并发症发生率、管路维护时间、置管期间的生活质量评分比较中来看，观察组各项指标显示更优，组间数值差异符合统计学标准（P＜0.05）。结论 对于化疗患者来说，想要确保静脉输液通路的安全与稳定，植入式静脉输液港是一种较好的选择，患者并发症发生率低、管路维护简单，临床具有较高的使用价值。

Abstract

Objective: To understand the specific application of PICC and implantable venous infusion port in the treatment of chemotherapy patients, and to observe and compare their use effects.
Methods: This study was carried out by patients with malignant tumors who received chemotherapy in our hospital, with a total of 58 cases, who were admitted from January to December 2021. According to the requirements, all patients were divided into two groups in a ratio of 1:1. Each group of patients used different intravenous infusion routes, including PICC and implantable intravenous infusion ports, respectively, corresponding to 29 patients, and the control group before and after. , the form of observation group to carry out a comparative study.
Results: From the comparison of the incidence of complications, the maintenance time of the pipeline, and the quality of life during the catheter placement, the observation group showed better results, and the numerical difference between the two groups was in line with the statistical standard (P<0.05).
Conclusion  : For chemotherapy patients, if they want to ensure the safety and stability of intravenous infusion access, implantable venous infusion port is a better choice. use value.